Emerging scale Catalyst OrthoScience is a mid-sized private medical device company (51-200 employees) with recent growth activity including a $15M financing round and FDA clearance activity, signaling momentum and potential for new product adoption and bigger contract opportunities.

Innovative offerings The company emphasizes surgeon-driven, anatomy-focused implants and streamlined single-tray instrumentation, highlighting opportunities to cross-sell across ORs, align to hospital procurement with faster case throughput, and promote value-based outcomes to payer discussions.

Awards momentum Recent MedTech Breakthrough recognition for the Catalyst Fracture System enhances credibility with health systems and surgeons, suggesting doors for strategic partnerships, clinical education programs, and contract pilots to leverage demonstrated innovation.

Clinical validation Data-backed, clinically validated results and emphasis on faster surgeries with reduced instrument processing costs point to opportunities in OR efficiency training, instrument lifecycle savings, and integration with existing surgical workflows.

Strategic leadership Board expansion and ongoing FDA clearance activity indicate a company open to strategic collaborations, distribution partnerships, and co-development opportunities that can expand geographic reach and accelerate adoption in shoulder arthroplasty markets.